ArticlePhysiological reports2025
Wearable and noninvasive monitoring of fluid shifts: A pilot study assessing a novel bioimpedance sensor during lower body negative pressure.
Article in Physiological reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Fluid extravasation is a prominent feature of several disease processes in acute and critical illness. Bioimpedance at frequencies representing extracellular and total resistance offers an opportunity to monitor fluid shifts. The aim of the present study was to explore if a novel wearable bioimpedance device could monitor fluid shifts during lower body negative pressure (LBNP). Eleven subjects underwent 40 min of LBNP at 30 mmHg. Bioimpedance was measured on the leg, upper back, and thoracic midaxillary line. Changes in resistance were compared using mixed linear regression. Further, hemoglobin and albumin concentrations were measured. Ten subjects completed the protocol. Compared to baseline, both extracellular and total resistance changed to the end of the LBNP exposure at all measurement sites. The mean extracellular resistance changed as follows: leg -6.6% (SD 3.1; p < 0.001), upper back 4.1% (SD 3.5; p < 0.001), and midaxillary line 6.3% (SD 2.8; p < 0.001). The wearable bioimpedance sensor detected the expected extracellular fluid shifts occurring with LBNP. Further clinical studies to explore if fluid extravasation in common pathologic conditions can be measured are warranted.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.